Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	Wozel G, Sticherling M. Systemische Psoriasistherapie – der nächste Schritt. Hautarzt 2007;58:515-8, 520-4. [PMID: 17492418 DOI: 10.1007/s00105-007-1338-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]

Number	Cited by Other Article(s)
1	Langley RG, Papp K, Bissonnette R, Toth D, Matheson R, Hultquist M, White B. Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies. Int J Dermatol 2010;49:818-28. [DOI: 10.1111/j.1365-4632.2010.04512.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Langley RG, Papp K, Bissonnette R, Toth D, Matheson R, Hultquist M, White B. Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies. Int J Dermatol 2010;49:818-28. [DOI: 10.1111/j.1365-4632.2010.04512.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]